Acurx Pharma's DNA Polymerase IIIC inhibitor antibiotics receives Japanese & Mexico patents
Acurx Pharmaceuticals, Inc., a late─stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult─to─treat bacterial infections, announced that the Japan Patent Office and the
📌 **Key Highlights**: • Official developments and latest press updates regarding Acurx Pharma's DNA Polymerase IIIC inhibitor antibiotics receives Japanese & Mexico patents. • Key insights, analysis, and verified reporting from authoritative sources. 📖 **Detailed Verified Report**: Today, major developments were reported regarding Acurx Pharma's DNA Polymerase IIIC inhibitor antibiotics receives Japanese & Mexico patents. Community leaders and domain experts emphasized the significance of these updates across Food, Lifestyle & Culture. Stay connected with Tolee News for verified real-time coverage.